Hydroxyamine

Hydroxyamine

SCHEMBL7951948

C=CCC(CC=C)(C(=O)O)S(=O)(=O)c1ccc(OC)cc1.NO

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 9/20 0.70
MMP13 P45452 9/20 0.70
MMP1 P03956 8/20 0.70
ADAM17 P78536 3/20 0.52
HTT P42858 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
PKM P14618 2/20 0.40
KEAP1 Q14145 1/20 0.40
NFE2L2 Q16236 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
CA12 O43570 2/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA9 Q16790 2/20 0.40
FFAR4 Q5NUL3 1/20 0.40
F2 P00734 1/20 0.39
PRSS1 P07477 1/20 0.39
PRSS2 P07478 1/20 0.39
PRSS3 P35030 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6930481 0.97 MMP13 (0.74) MMP9MMP13MMP1ADAM17HTT
Hydroxyamine SCHEMBL8229937 0.88 MMP13 (0.60) MMP9MMP13MMP1ADAM17HTT
SCHEMBL8223970 0.85 MMP13 (0.62) MMP9MMP13MMP1ADAM17HTT
SCHEMBL6928954 0.83 MMP13 (1.00) MMP9MMP13MMP1ADAM17
SCHEMBL6932341 0.82 MMP13 (0.74) MMP9MMP13MMP1ADAM17HTT
Hydroxyamine SCHEMBL7685608 0.82 MMP9 (0.55) MMP9MMP13MMP1ADAM17HTT
SCHEMBL6931611 0.82 MMP9 (0.67) MMP9MMP13MMP1ADAM17HTT
SCHEMBL7622218 0.79 MMP13 (0.57) MMP9MMP13MMP1ADAM17HTT
SCHEMBL8229938 0.78 MMP1 (0.58) MMP9MMP13MMP1ADAM17ALDH1A1
SCHEMBL8227693 0.75 MMP13 (0.79) MMP9MMP13MMP1ADAM17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6331563-B1 LOW MOLECULAR WEIGHT, NON-PEPTIDE INHIBITORS OF MATRIX METALLOPROTEINASES AND TUMOR NECROSIS FACTOR-ALPHA CONVERTING ENZYME; TREATING ARTHRITIS, TUMOR METASTASIS, ABNORMAL WOUND HEALING, PERIODONTAL DISEASE, BONE DISEASE, INSULIN RESISTANCE WYETH HOLDINGS CORPORATION 2001-12-18 US disclosed